# Efficacy and Safety of NVP-NK4146 in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease

> **NCT06761066** · NA · NOT_YET_RECRUITING · sponsor: **NVP Healthcare** · enrollment: 60 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DIETARY_SUPPLEMENT:** NVP-NK4146
- **DIETARY_SUPPLEMENT:** NVP-NK4146 Placebo

## Key facts

- **NCT ID:** NCT06761066
- **Lead sponsor:** NVP Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-04-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06761066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06761066, "Efficacy and Safety of NVP-NK4146 in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06761066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*